Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings
Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings in the Treatment of Partial Thickness Burns
Sponsor: Melva Louisa
Terminated
Stopped by the Sponsor due to their change in product development priorities.
Listed as NCT03190655, this NA trial focuses on Partial-thickness Burn and remains terminated or withdrawn. Sponsored by Melva Louisa, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Study Description(click to expand)This is a prospective, randomized, open label, active controlled trial that aim to evaluate the efficacy and safety of Aluminaid versus Hydrogel wound dressings in the treatment of partial thickness burns.
The study is a multi center trial in children and adults of 12 - 65 years old with partial thickness burns.
This is a prospective, randomized, open label, active controlled trial that aim to evaluate the efficacy and safety of Aluminaid versus Hydrogel wound dressings in the treatment of partial thickness burns.
The study is a multi center trial in children and adults of 12 - 65 years old with partial thickness burns.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Mar 2018 — Jun 2018 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 1 earlier version
-
Aug 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Melva Louisa
For direct contact, visit the study record on ClinicalTrials.gov .